Product Information
FERRIC CITRATE 210 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $6.3712 per EA under NDC 00378289520. Its NADAC has been published 45 times since Aug 20, 2025.
Strength
210 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378289520
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
TETRAFERRIC TRICITRATE DECAHYDRATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA205874On Market Since
3/20/2025
Pharmacological Classes
Price Statistics
The NADAC for FERRIC CITRATE 210 MG TABLET has been published 45 times since Aug 20, 2025, and over the history we have for it it has risen 11.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.3712 per EA |
|---|---|
| All-time high | $6.3712 (Jun 24, 2026) |
| All-time low | $5.7002 (Aug 20, 2025) |
| 52-week high | $6.3712 |
| 52-week low | $5.7002 |
| Median price | $6.1635 |
| Average price | $6.1334 |
| Largest weekly change | +3.4% (Sep 17, 2025) |
| Weeks tracked | 45 |
| Tracking since | Aug 20, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Ferric Citrate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of FERRIC CITRATE 210 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FERRIC CITRATE 210 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $6.3712 per EA (NDC 00378289520), effective Jun 24, 2026.
How has the price of FERRIC CITRATE 210 MG TABLET changed over time?
Over the history we have for it, the NADAC for FERRIC CITRATE 210 MG TABLET has risen 11.8%. It has been tracked across 45 weekly CMS publications since Aug 20, 2025.
What are the highest and lowest recorded NADAC prices for FERRIC CITRATE 210 MG TABLET?
Since Aug 20, 2025, the NADAC for FERRIC CITRATE 210 MG TABLET has ranged from a low of $5.7002 (Aug 20, 2025) to a high of $6.3712 (Jun 24, 2026), with a median of $6.1635 per EA.
Are there cheaper alternatives to FERRIC CITRATE 210 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of FERRIC CITRATE 210 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures FERRIC CITRATE 210 MG TABLET?
FERRIC CITRATE 210 MG TABLET (NDC 00378289520) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification